IFIB 2026

1 – 2 Oct 2026 | Roma, Italy

Register
Register
Register

PartnershipUpdated on 9 September 2026

Three proprietary actives from fermentation, looking for formulators and distributors

General Manager at BiCT srl

Lodi, Italy

About

Three actives developed and produced by BiCT. Lactive is a patented bioactivated lactoferrin, up to twenty times more active than the intact protein, with peptides small enough to penetrate the skin; it covers acne-prone skin, anti-age, atopic skin, scalp, oral and intimate care, and has two clinical trials behind it. Evobiom is a postbiotic from a documented Lacticaseibacillus rhamnosus strain, characterised by exometabolomics with the University of Bari: same INCI as others on the market, different content, with a declared strain rather than an anonymous one. ExoLife Rh is extracellular vesicles from precision fermentation, working on barrier, microcirculation and skin tone, effective from 0.1% to 1%. Distribution is already active in Italy, Spain, Poland, India, China, South Korea, New Zealand and the Philippines. Samples and technical packages on request, under confidentiality.

Similar opportunities